Company Strategy and Performance - Gibson Energy aims for a total shareholder return of over 100% by 2030[53] - The company targets a 7%+ average annual Infrastructure EBITDA per share growth[74, 107] - Gibson Energy's cost focus initiative drove operational excellence, recognizing $25 million in run-rate cost savings in 2025[31] - The company returned over $1.4 billion to shareholders since 2021[51, 87] Infrastructure and Operations - Gibson Energy has >25 mmbbl tankage capacity in North America[7] - The company achieved record throughput of 2.3 mmbbl/d across Canadian and U S terminals in 2025[30] - >95% of Q3 2025 Segment Profit came from Infrastructure[7] - >85% of Terminals Revenue is from Investment Grade customers[7] Financial Position and Outlook - The company targets capital investment of $100-150 million at 5–7x build multiples[33] - Gibson Energy expects to deploy up to $1 billion of growth capital over the next five years[66] - The company's dividend yield is 6.9%[7]

Financial Highlights - FY25 Pre-Tax Pre-Provision earnings increased by 9%, with adjusted earnings up by 15%[13] - FY25 revenues increased by 12%[15] - Q4 Return on equity was 11%, with adjusted return on equity at 12.5%, a year-over-year increase of 190 bps[15] - The company repurchased 10.8 million shares in FY25[15] - CET1 ratio stood at 13.2%[15] Segment Performance - Canadian Banking: Q4 pre-tax pre-provision earnings increased by 3% year-over-year[15] - International Banking: Q4 Net Interest Margin (NIM) increased by 12 bps year-over-year[15] - Global Wealth Management: FY25 net income increased by 18%, with operating leverage of 1.6% and net sales improved by $11.5 billion[15] - Global Banking and Markets: FY25 net income increased by 30%, with underwriting and advisory fees up by 35%[15] Capital Position and Risk Management - Q/Q CHANGE IN CET1 RATIO decreased by ~10 basis points Q/Q[25] - Total ACL ratio of 98 bps, up 2 bps Q/Q[57] - GILs are higher Q/Q by $354 million due primarily to formations mainly in Canadian Retail and Corporate portfolios, as well as the impact of foreign currency translation[68]

Q3 2025 Earnings Presentation BW LPG Kristian Sørensen and Samantha Xu 2 December 2025 Disclaimer and forward-looking statements NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR IN TO ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. BY ATTENDING THE MEETING WHERE THIS PRESENTATION IS MADE, OR BY READING THE PRESENTATION SLIDES, YOU ACKNOWLEDGE AND AGREE TO COMPLY WITH THE FOLLOWING RESTRICTIONS. This presentation has been produced by BW LPG Li ...

BEACON Trial Investigation Results - Internal investigation indicates anomalous efficacy results in the BEACON trial are likely due to patient-specific factors rather than issues with the drug product or study conduct[23] - A KOL panel review suggested that 9 out of 10 patients who did not respond in the US may not have had CSU, highlighting potential misdiagnosis issues common in CSU studies where 25%-30% of patients are incorrectly diagnosed[40] - Redosing Cohort 8 & 9 patients with a different drug product lot did not significantly change efficacy outcomes, with no incremental efficacy observed in 8 of 9 patients redosed[27, 31] - In the BEACON trial, 7 of 10 US patients in Cohorts 8 & 9 were switched to a different drug product lot by week 16[27, 31] ETESIAN Trial Interim Results - A single 180mg dose of Briquilimab in the ETESIAN study demonstrated a reduction in serum tryptase levels at 6 weeks, consistent with previous observations[45] - Briquilimab mitigated the effects of allergen challenge on FEV1 response, showing a sustained impact on asthmatic response at 6 and 12 weeks[47] - Briquilimab dramatically reduced airway hyper-responsiveness, increasing the concentration of methacholine needed to drive a 20% drop in FEV1 (PD20)[51] - Sputum eosinophil response was suppressed by Briquilimab at both 6-week and 12-week allergen challenge timepoints[53] Program Status and Next Steps - In CSU, single doses of 240mg and 360mg of Briquilimab led to more than a 24-point drop in UAS7, with 82% CR and 91% WC disease by week 4 (n=11)[60] - In an OLE study for CSU, 180mg Q8W of Briquilimab resulted in 73% CR and 82% WC disease at 12 weeks (n=11)[60]

This presentation may include statements expressing Vale's expectations regarding future events or results, including, without limitation : (i) on slide 5 , iron ore, copper, and nickel production guidance in 2025 ; (ii) on slide 6 , completion of dam decharacterization projects and emergency level reductions ; (iii) on slides 11 and 19 , leading positions in value creation in the mining industry and iron ore production, in addition to accelerating growth to double copper production capacity, (iv) on slide ...

Financial Performance & Outlook - ONE Gas expects net income for 2026 to be in the range of $294 million to $302 million[12] - The company anticipates an EPS range of $4.65 to $4.77 per diluted share, assuming approximately 63.4 million diluted shares outstanding[12] - Long-term net income growth is projected at 7-9% for the 2025-2030 period[21] - Long-term EPS growth is expected to be 5-7%, raised from a previous estimate of 4-6%[21] Capital Investments & Rate Base - 2026 capital investments are estimated at approximately $800 million, with around $230 million allocated to customer growth[12] - The average rate base for 2026 is projected to be approximately $6.3 billion[12] - Capital investments from 2022 to 2026G are: System Integrity ~$2.5 billion, Customer Growth ~$1.2 billion[21] - Average annual rate base growth is expected to be 7-9%[21] Financing Activities - ONE Gas completed a $250 million term loan in August 2025, maturing in September 2026[12] - The company has forward sale agreements covering approximately 2.9 million shares at an average price of ~$78/share, totaling ~$226 million[12, 16] - Net long-term financing needs through 2030 are estimated at ~$1.3 billion, with approximately 30% expected to be equity issuances[14] Market Position - ONE Gas has a 71% market share in Kansas, 89% in Oklahoma, and 13% in Texas[8]

Forward-Looking Statements - Certain statements constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995 [3] - These statements are based on expectations and assumptions that may not be accurate [3] - Actual results could differ materially due to various risks, uncertainties, and circumstances [3] - The company assumes no obligation to update or revise any forward-looking statement [4] Risk Factors - General economic and industry conditions, including regulatory changes, pose risks [3] - Reliance on commercial airline customers is a significant factor [3] - The health of the aircraft production system and production quality issues are critical [3] - Dependence on subcontractors and suppliers, as well as labor and raw material availability, are important [3] - The pending acquisition of Spirit AeroSystems Holdings, Inc presents both opportunities and risks [3] - Potential business disruptions, including IT system threats and extreme weather, could have adverse effects [3]

Energy Storage Systems for Data Centers - The global server market is experiencing a compound annual growth rate (CAGR) of 34% from 2023 to 2028, driven by AI server adoption[15] - Panasonic Energy aims to achieve sales of 800 billion yen by FY2029 through increased demand for existing and next-generation products[28] - Panasonic Energy targets a Return on Invested Capital (ROIC) greater than 20% for its Energy Solutions Business Division by FY2029[46] - Panasonic Energy plans to increase cell production capacity by approximately 3 times by FY2029 compared to FY2026 levels[35] Electrical Construction Materials Business - Panasonic Electric Works aims to increase overseas sales to account for 35% of total sales by FY3/31, including 200 billion yen in India[62] - The Japanese market for electrical equipment is expected to grow at a CAGR of 0.7% from FY3/23 to FY3/31, reaching 2 trillion yen[59] - The Indian market for electrical equipment is projected to grow at a CAGR of 9.1% from FY3/23 to FY3/31, reaching 3.6 trillion yen[59] - Panasonic Electric Works targets a solutions sales ratio of 50% in Japan by FY3/31, up from 36% in FY3/25[88] SCM Software - The SCM software market is projected to reach 66553 million USD by 2029[99] - Blue Yonder's revenue for FYDec'24 was 1360 million USD[102] - Blue Yonder has achieved 150 million USD in cumulative cost savings as of 2025[114]

CANGO 03-2025 Earnings Presentation December 2025 CANG LISTED ENYSE 1 2 Mined a total of 1,930.8 BTC during the quarter, bringing the Company's BTC treasury to 5,810.1 BTC by quarter end. 5,810.1 BTC HODL as of September 30, 2025 $662.3 M Value of BTC HODL 2 as of September 30, 2025 Q3 Operational Highlights Cango operates 50 EH/s of deployed hashrate globally and maintains an average operating efficiency above 90% since November 2024 till September 2025. 50 EH/s Deploved Hashrate as of September 30 , 2025 ...

Portfolio Repositioning and Performance - Broadstone Net Lease (BNL) reduced clinical healthcare exposure to 2.4% of the portfolio ABR since the beginning of 2024[25] - BNL successfully sold 57 clinical healthcare assets for $352 million in 2024[25] - BNL grew AFFO per share by 1.4% in 2024 despite portfolio repositioning[25] - BNL's industrial exposure increased from 51.8% to 61.2% between March 31, 2023, and September 30, 2025[89] Growth Strategy and Build-to-Suit Developments - BNL has committed or completed $898 million in build-to-suit developments since 2023[25,59] - This includes $583 million of new build-to-suit commitments in 2025, expected to result in $29.1 million of incremental ABR through 1Q27[25,52] - BNL's build-to-suit strategy creates stabilized values approximately 75-100 bps tighter than initial cash yields[25] Financial Guidance and Shareholder Value - BNL's 2026 AFFO per share guidance is $1.53 - $1.57[329] - BNL's total shareholder return since the beginning of 2023 is 32.8%[25] - BNL's 2025 investment guidance is $650 - $750 million, and dispositions are $75 - $100 million[329]